A First-in-Human Study of FID-022 in Solid Tumor Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A First-in-Human Study of FID-022 in Solid Tumor Patients — Stella

Recruiting

Back to Pancreatic Cancer trials

Trial locations(1 site)

United States

Moffitt Cancer Center, Tampa, Florida

Key details

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

Florida Cancer Innovation Fund

Enrollment target

~120 participants

Started

October 2025

Primary completion

October 2026

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov